Press "Enter" to skip to content

New patent for Indivior Inc drug SUBOXONE


Annual Drug Patent Expirations for SUBOXONE
Annual Drug Patent Expirations for SUBOXONE

Suboxone is a drug marketed by Indivior Inc
and is included in two NDAs. It is available from five suppliers. There are four patents protecting this drug and three Paragraph IV challenges.

This drug has one hundred and thirty patent family members in twenty-five countries.

The generic ingredient in SUBOXONE is buprenorphine hydrochloride; naloxone hydrochloride. Five suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!